
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [BMY] Bristol-Myers Squibb Co.
Data updated 2025-May-23 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-23 Friday
Open | $46.93 | High | $47.16 +0.49% |
---|---|---|---|
Close | $46.85 | Low | $46.49 -0.94% |
Volume | 8.4 Million 0.68x | Volatility | 1.44% |
Change |
$-0.18
-0.38%
|
Streak | ↓ 1 days -0.38% |
20d SMA | $47.70 -1.8% | 50d SMA | $52.26 -10.4% | 100d SMA | $55.03 -14.9% | 200d SMA | $54.16 -13.5% |
RSI | 42 | MACD | 0.32 | ADX | 36.2 | Stochastic Oscillator | 46.7 49.0 |
CCI | -47.6 | ATR | 1.45 | OBV | 457 Million | Chaikin A/D | 687 Million |
Market Cap | 99.6 B | PEG Ratio | 2.23 | Trailing P/E | 12.7 | Forward P/E | 6.92 |
Price/Sales (ttm) | 2.27 | Price/Book (mrq) | 3.38 | EV/Revenue (ttm) | 2.86 | EV/EBITDA (ttm) | 6.65 |
% Held by Insiders | 0.10% | % Held by Institutions | 78.94% | Shares Short | 35.1 M | Shares Short (prior month) | 32.7 M |
Short Ratio | 1.77 | Short % of Outstanding | 1.73% | Short % of Float | 1.74% | Shares Short Change (mom) | +7.6% |
Revenue/Share (ttm) | $21.75 | Profit Margin (ttm) | 17.83% | Operating Margin (ttm) | 17.01% | EBITDA (ttm) | 18.4 B |
Diluted EPS (ttm) | $3.86 | Current Ratio (mrq) | 1.43 | Return on Assets (ttm) | 5.63% | Return on Equity (ttm) | 26.53% |
Qtr Earnings Growth (yoy) | -12.90% | Qtr Revenue Growth (yoy) | 0.60% | Operating Cash Flow (ttm) | 13.9 B | Free Cash Flow (ttm) | 13.8 B |
Choose view type
Monthly Performance for Bristol-Myers Squibb Co.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Bristol-Myers Squibb Co. up to close of 2025-May-23 at $46.85
3-month Performance Benchmarks for Bristol-Myers Squibb Co.:
Related to Bristol-Myers Squibb Co.
Information for Bristol-Myers Squibb Co.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-23 on Google
SEC Reports : Quarterly reports around 2025-May-23 on SEC Edgar
Compare Bristol-Myers Squibb Co. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Bristol-Myers Squibb Co.
Industry : Pharmaceuticals industry performance which includes Bristol-Myers Squibb Co.